Patrick Mismetti - Concepedia

Author

Patrick Mismetti

Centre Hospitalier Universitaire de Saint-Étienne

Also Known As

Céline Bazzoli, Mismetti, P., Mismetti, Patrick, N. Rosencher, Odile Blanchet, P Mismetti, P. MISMETTI, P. Mismetti, PATRICK MISMETTI, Patrick Mismetti

208

Publications

12.1K

Citations

H-Index

104

Concepts

All Affiliations

Centre Hospitalier Universitaire de Saint-Étienne Inserm Hôpital Nord Assistance Publique – Hôpitaux de Paris Université Paris Cité

About

Patrick Mismetti is an author at Centre Hospitalier Universitaire de Saint-Étienne specializing in medicine, thrombosis, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	33	3.8K
2	Public Health	5	5	495
3	Health Sciences	4	4	212
4	Anesthesia	2	2	119
5	Engineering	1	1	35

Patrick Mismetti

Publications

8.7K

Citations

H-Index

Page 1

	Year	Citations
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism Sam Schulman, Clive Kearon, Ajay K. Kakkar, New England Journal of Medicine	2009	2.5K
Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism Sam Schulman, Clive Kearon, Ajay K. Kakkar, New England Journal of Medicine	2013	977
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis Sam Schulman, Ajay K. Kakkar, Samuel Z. Goldhaber, Circulation	2013	923
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial Sonia S. Anand, Jackie Bosch, John W. Eikelboom, The Lancet ThrombosisCardiovascular DiseaseStrokeMedicinePlacebo-controlled Trial	2017	855
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial Stuart J. Connolly, John W. Eikelboom, Jackie Bosch, The Lancet ThrombosisCardiovascular DiseaseAtherosclerosisMedicineCoronary Artery Disease	2017	749
Clinical Outcome of Patients With Upper-Extremity Deep Vein Thrombosis Francisco J. Muñoz, Patrick Mismetti, Renzo Poggio, CHEST Journal ThrombosisPulmonary EmbolismVenous ThrombosisCardiovascular DiseaseHematology	2007	316
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) – March 2013 Gilles Pernod, Pierre Albaladejo, Anne Godiér, Archives of cardiovascular diseases ThrombosisDirect Oral AnticoagulantsCardiovascular DiseaseMedicineHematology	2013	305
Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study Marc Rodger, Grégoire Le Gal, David R. Anderson, BMJ	2017	232
Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism Benjamin Planquette, Laurent Bertoletti, Anaïs Charles‐Nelson, CHEST Journal ThrombosisVenous ThrombosisRivaroxaban Vs DalteparinStrokeMedicine	2021	142
Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin Isabelle Gouin‐Thibault, Xavier Delavenne, Anne Blanchard, Journal of Thrombosis and Haemostasis Health SciencesAntibioticsAbcb1 Genetic PolymorphismsMedicineGenetics	2016	139

Page 1